Chemed Corporation (CHE) - Stock Analysis
Last updated: Jun 13, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong margins ⢠Liquidity pressure ⢠Higher leverage CHE remains highly profitable and cash-generative, but weaker liquidity, higher leverage, and a full valuation temper the upside.
Price Behavior
Key Price Behavior Insights: ⢠Failed breakout ⢠Support holding ⢠Momentum fading Support Level: $417-$420 Resistance Level: $426-$427, then $434-$446 CHE weakened slightly over the last month, with a brief breakout to $446.26 failing and momentum now looking cautious unless it reclaims $426-$427 while holding $417-$420.
Sentiment & News
Key News Insights: ⢠Quarterly Dividend ⢠Texas Expansion ⢠Governance Routine Chemed's recent headlines were mostly routine and constructive, marked by governance updates, a quarterly dividend, investor outreach, and Roto-Rooter's $12M south Texas franchise acquisition.
AI Summary
CHE should be viewed less as a steady defensive compounder and more as a two-engine story where VITAS is driving the upside while Roto-Rooter's margin erosion and a weaker balance sheet are the main risks, so the stock likely depends on sustained hospice volume growth to justify its rich valuation.
Description
Chemed Corporation delivers hospice and palliative care through a multidisciplinary network of clinicians, aides, social workers, clergy and volunteers across the United States under its VITAS segment, and provides plumbing, drain, excavation and water-restoration services to residential and commercial customers via company branches, independent contractors and franchisees under its Roto-Rooter segment. The company operates these two distinct businesses from its headquarters in Cincinnati and has been incorporated since 1970.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CHE | Chemed Corporation | Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization. | Closed | +1.5% |